Synaptic transmission is a fundamental cell-cell signaling process that underlies basic physiological processes such as sensation, movement, and feeding. Deregulation of synaptic transmission occurs in a variety of human diseases or conditions, including Alzheimer's disease, epilepsy, and schizophrenia. However, the mechanisms that modulate neurotransmitter release are not well understood. We are studying the locomotory behavior of C. elegans to better understand neuromodulatory mechanisms that regulate nervous system activity. We have found that mutations in the gene
vav-1, which encodes an evolutionarily conserved Rac GTPase family guanine nucleotide exchange factor (GEF), result in an elevated rate of locomotion. This and other
vav-1 mutant phenotypes are consistent with elevated acetylcholine release. Nevertheless,
vav-1 null mutants exhibit normal sinusoidal patterns of locomotion and the nervous system develops normally in these animals. We found that restoration of VAV-1 expression in only cholinergic neurons restores the elevated locomotion rate of
vav-1 mutant worms to wild type levels. We also determined that the hyperactive phenotype of
vav-1 mutants is dependent on synaptic vesicle (SV) release. In transgenic animals, cholinergic VAV-1::GFP fluorescence is present at neuromuscular junctions. Furthermore,
vav-1 mutants have normal distribution of synaptic vesicle-associated proteins GFP::SNB-1 and Venus::RAB-3 at cholinergic neuromuscular junctions, but the fluorescence intensity of these proteins at synapses is altered. This may indicate that the neuronal role of VAV-1 is to organize synaptic release machinery, or to inhibit synaptic vesicle release in a more direct manner, at existing synapses. Currently, we are testing the requirement of enzymatic GEF activity for normal function of neuronal VAV-1, investigating the distribution of further neuromuscular junction proteins in
vav-1 mutants, and determining whether cholinergic expression of VAV-1 rescues abundance of synaptic proteins to wild type levels. Taken together, our results unveil a novel role for Vav proteins in an inhibitory neuromodulatory signaling pathway.